Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Paclitaxel × Genitourinary × Clear all

Phase

Status

Completed 69 Terminated 10 Recruiting 10 Active not recruiting 7 Unknown 6 Withdrawn 5 Suspended 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 20 Thoracic 16 Breast 16 Gastrointestinal 12 Head & Neck 5 Other solid neoplasm 3 Tumor-Agnostic 2 Sarcoma 1 Plasma cell 1 Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Androgen Antagonists 13 Gemcitabine 11 Radiotherapy 10 pembrolizumab 9 darolutamide 9 Specimen Handling 9 Radiosurgery 9 Docetaxel 9 Drug Therapy 6 Abiraterone Acetate 6 apalutamide 5 abiraterone 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Cystectomy 5 Brachytherapy 5 Biopsy 5 enzalutamide 4 disitamab vedotin 4 Pluvicto 4 Mitomycin 4 toripalimab 3 lenvatinib 3 enfortumab vedotin 3 cabozantinib 3 Prednisone 3 Leuprolide 3 Ipilimumab 3 Glutamate Carboxypeptidase II 3 Epirubicin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07419295 2026-02-19

TroFuse-031

Merck Sharp & Dohme LLC

Phase 3 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡